These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15803287)

  • 1. [The effect of combined mitoxantrone and methylprednisolone therapy in primary and secondary progressive multiple sclerosis. An applied study in 65 patients].
    Zingler VC; Strupp M; Jahn K; Gross A; Hohlfeld R; Brandt T
    Nervenarzt; 2005 Jun; 76(6):740-7. PubMed ID: 15803287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
    Le Page E; Leray E; Edan G;
    Mult Scler; 2011 Jul; 17(7):867-75. PubMed ID: 21325016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aggressive multiple sclerosis. Definition and specific therapeutic indication].
    Edan G
    Presse Med; 2004 Feb; 33(3):187-91; discussion 192. PubMed ID: 15029034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients].
    Le Page E; Leray E; Taurin G; Coustans M; Chaperon J; Edan G
    Rev Neurol (Paris); 2006 Feb; 162(2):185-94. PubMed ID: 16518258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive parameters of mitoxantrone effectiveness in the treatment of multiple sclerosis.
    Debouverie M; Vandenberghe N; Morrissey SP; Anxionnat R; Pittion-Vouyovitch S; Vespignani H; Edan G
    Mult Scler; 2004 Aug; 10(4):407-12. PubMed ID: 15327038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical follow-up of 411 patients with relapsing and progressive multiple sclerosis 10 years after discontinuing mitoxantrone treatment: a real-life cohort study.
    Chartier N; Epstein J; Soudant M; Dahan C; Michaud M; Pittion-Vouyovitch S; Guillemin F; Debouverie M; Mathey G
    Eur J Neurol; 2018 Dec; 25(12):1439-1445. PubMed ID: 29996003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.
    Humm AM; Z'Graggen WJ; Bühler R; Magistris MR; Rösler KM
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):345-50. PubMed ID: 16174651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
    Ratzer R; Iversen P; Börnsen L; Dyrby TB; Romme Christensen J; Ammitzbøll C; Madsen CG; Garde E; Lyksborg M; Andersen B; Hyldstrup L; Sørensen PS; Siebner HR; Sellebjerg F
    Mult Scler; 2016 Jun; 22(7):926-34. PubMed ID: 26432857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitoxantrone therapy in rapidly worsening multiple sclerosis.
    Benesova Y; Stourac P; Beranek M; Kadanka Z
    Bratisl Lek Listy; 2005; 106(3):141-3. PubMed ID: 16026151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial.
    Krapf H; Morrissey SP; Zenker O; Zwingers T; Gonsette R; Hartung HP;
    Neurology; 2005 Sep; 65(5):690-5. PubMed ID: 16157900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients.
    Voltz R; Starck M; Zingler V; Strupp M; Kolb HJ
    Mult Scler; 2004 Aug; 10(4):472-4. PubMed ID: 15327049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe delayed heart failure in three multiple sclerosis patients previously treated with mitoxantrone.
    Goffette S; van Pesch V; Vanoverschelde JL; Morandini E; Sindic CJ
    J Neurol; 2005 Oct; 252(10):1217-22. PubMed ID: 15834643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mitoxantrone use in primary and secondary progressive multiple sclerosis - study site experience based on the therapy of 104 patients.
    Lasek-Bal A; Bartoszek K; Steposz A; Puz P; Bal W; Kazibutowska Z
    Int J Neurosci; 2017 Oct; 127(10):859-863. PubMed ID: 27919195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis.
    Cursiefen S; Flachenecker P; Toyka KV; Rieckmann P
    Eur Neurol; 2000; 43(3):186-7. PubMed ID: 10765063
    [No Abstract]   [Full Text] [Related]  

  • 16. Mitoxantrone reduced disability in Iranian patients with multiple sclerosis.
    Hamzehloo A; Etemadifar M
    Arch Iran Med; 2007 Jan; 10(1):59-64. PubMed ID: 17198456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitoxantrone in secondarily progressive multiple sclerosis: a series of 18 patients.
    Montú MB; Arruda WO; de Oliveira Mde S; Ramina R
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):225-7. PubMed ID: 16100967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.
    Zamboni P; Galeotti R; Menegatti E; Malagoni AM; Gianesini S; Bartolomei I; Mascoli F; Salvi F
    J Vasc Surg; 2009 Dec; 50(6):1348-58.e1-3. PubMed ID: 19958985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients.
    Zephir H; de Seze J; Duhamel A; Debouverie M; Hautecoeur P; Lebrun C; Malikova I; Pelletier J; Sénéchal O; Vermersch P
    J Neurol Sci; 2004 Mar; 218(1-2):73-7. PubMed ID: 14759636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety.
    Zipoli V; Portaccio E; Hakiki B; Siracusa G; Sorbi S; Amato MP
    J Neurol Sci; 2008 Mar; 266(1-2):25-30. PubMed ID: 17870094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.